3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
17
Colonic Neoplasms
15
Rectal Neoplasms
11
Stomach Neoplasms
10
Ovarian Neoplasms
6
Neoplasms
5
Gastrointestinal Stromal Tumors
5
Carcinoma, Hepatocellular
5
Uterine Cervical Neoplasms
3
Pancreatic Neoplasms
3
Liver Neoplasms
3
Endometrial Neoplasms
3
Carcinoma, Renal Cell
3
Prostatic Neoplasms
2
Peritoneal Neoplasms
2
Neoplastic Cells, Circulating
2
Kidney Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
2
Venous Thrombosis
1
Uterine Neoplasms
1
Surgical Wound Infection
1
Robotic
1
Polycystic Ovary Syndrome
1
Pancreatic Neuroendocrine Tumors
1
Ornithine Carbamoyltransferase Deficiency Disease
1
Obesity, Morbid
1
Neurologic Manifestations
1
Neuroendocrine Tumors
1
Neoplasm Metastasis
1
Interventions
Sorafenib
4
Blood Specimen Collection
4
lenvatinib
3
sintilimab
2
halofantrine
2
camrelizumab
2
Liver Transplantation
2
Antibodies
2
trametinib
1
toripalimab
1
titanium silicide
1
tislelizumab
1
pembrolizumab
1
ledipasvir, sofosbuvir drug combination
1
genexol-PM
1
gadolinium ethoxybenzyl DTPA
1
fluorocholine
1
bavituximab
1
avatrombopag
1
aumolertinib
1
atezolizumab
1
User-Centered Design
1
Sunitinib
1
Sufentanil
1
Sofosbuvir
1
Shadowing Technique, Histology
1
Ropivacaine
1
Ribavirin
1
Radiotherapy
1
Radiosurgery
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Liver Diseases
×
Laparoscopy
×
Clear all
NCT01567631
2016-02-01
LAHIGA
Southwest Hospital, China
Phase NA
Unknown
80 enrolled